Monitoring symptoms to help young women with breast cancer stay on treatment
Active Symptom Monitoring and Endocrine Therapy Persistence in Young Women with Breast Cancer
This study is all about helping young women with hormone receptor positive breast cancer feel better during their treatment by using a handy online tool to share their symptoms, so doctors can help them manage any side effects and keep them on track with their therapy for a better quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11019794 on NIH RePORTER |
What this research studies
This research focuses on improving the experience of young women with hormone receptor positive breast cancer by actively monitoring their symptoms during endocrine therapy. The study aims to use a web-based tool that allows patients to report their symptoms, which can help healthcare providers address issues early and improve treatment adherence. By identifying and managing treatment-related side effects, the research seeks to enhance the quality of life and reduce the likelihood of treatment discontinuation. The goal is to evaluate how effective this approach is in helping patients continue their therapy and ultimately improve their health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are premenopausal women diagnosed with hormone receptor positive breast cancer who are starting endocrine therapy.
Not a fit: Patients with breast cancer who are not premenopausal or those who are not receiving endocrine therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better management of treatment side effects, allowing patients to stay on their therapy longer and potentially improving their survival rates.
How similar studies have performed: Previous research has shown that active symptom monitoring can improve quality of life and survival in advanced cancer, but this approach is relatively novel in early-stage breast cancer.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Henry, Norah Lynn — University of Michigan at Ann Arbor
- Study coordinator: Henry, Norah Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.